High Court considers requirements for an exclusive patent licence (Neurim v Mylan)

http://www.twobirds.com/en/patenthub/shared/articles/2020/uk/high-court-considers-requirements-for-an-exclusive-patent-licence

In the LexisNexis case analysis, Senior IP Associate, Will Smith, talks about the decision in the following matter: Neurim Pharmaceuticals (1991) Ltd & Anor v Generics UK Ltd (t\a MYLAN) [2020] EWHC 3270 (Pat). This case concerned the licensing of patented ...

22 December 2020

Legal Alert: Changes in the Polish Industrial Law concerning patents

http://www.twobirds.com/en/patenthub/shared/articles/2020/poland/legal-alert-changes-in-the-polish-industrial-law-concerning-patents

A summary of the recent changes to the Polish Industrial Law concerning patents (enacted in October 2019, entering into force on 27 February 2020).

30 January 2020

Licensing Markets

http://www.twobirds.com/en/patenthub/shared/articles/2019/global/licensing-markets

When a defendant loses a patent trial, when would they decide that submitting to an injunction is better than taking a license? Tristan Sherliker reports on this in the September Issue of The Licensing Journal by Wolters Kluwer

13 November 2019

Bird & Bird secures win in preliminary injunction patent case before the Düsseldorf Courts

http://www.twobirds.com/en/patenthub/shared/articles/2019/germany/bird-and-bird-secures-win-in-preliminary-injunction-patent-case-before-the-dusseldorf-courts

On September 26, 2019, the Higher Regional Court of Düsseldorf confirmed on appeal that Teva Pharmaceutical Industries Ltd. (“Teva”) – one of Bird & Bird’s key clients – is entitled to a preliminary injunction against Mylan dura GmbH (“Mylan”) in Germany. ...

30 September 2019

Patents: meaning of enablement in anticipation by prior art

http://www.twobirds.com/en/patenthub/shared/articles/2019/global/patents-meaning-of-enablement-in-anticipation-by-prior-art

The Patents Court has considered enablement in relation to anticipation of a claimed monoclonal antibody invention by prior art, and held the patent was invalid for lack of novelty; it was also obvious for lack of technical contribution, and insufficient for ...

04 September 2019